home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

An Alternative To Fetal Tissue As A Source Of Viable Human Brain Cells

 
  May, 3 2001 6:14
your information resource in human molecular genetics
 
     
Brain Researchers have identified another alternative to fetal tissue as a source of viable human brain cells. In a Brief Communication (Nature, Vol. 411, No. 6833, 03 May 2001), Fred Gage, of the Salk Institute, La Jolla, California, and colleagues describe their feat of culturing neural progenitor cells from the brains of cadavers.

Gage and colleagues were able to extract viable cells from most of the 23 post-mortem brains they examined. The ages of the deceased ranged from a few weeks to adult, and functioning cells were obtained up to 20 hours after death.

The possible medical applications of this work are still hazy, and, although ethically less fraught, these post-mortem cells are not as powerful as those from fetal tissue. But the research raises the hope that neural progenitor cells, like organs, could one day be taken from the dead and given to the living.

CONTACT:

Fred Gage
tel +1 858 453 4100 ext 1012
e-mail gage@salk.edu

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.